Legend Biotech Corp logo

Legend Biotech Corp - ADR

1
NAS:LEGN (USA)   ADR
$ 67.78 -2.21 (-3.16%) 04:00 PM EST
At Loss
P/B:
9.52
Market Cap:
$ 12.76B
Enterprise V:
$ 11.66B
Volume:
727.16K
Avg Vol (2M):
918.36K
Also Trade In:
Volume:
727.16K
At Loss
Avg Vol (2M):
918.36K

Business Description

Legend Biotech Corp logo
Legend Biotech Corp
NAICS : 541714 SIC : 2834
ISIN : US52490G1022

Share Class Description:

LEGN: ADR
Description
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America.
Name Current Vs Industry Vs History
Cash-To-Debt 4.44
Equity-to-Asset 0.73
Debt-to-Equity 0.24
Debt-to-EBITDA -0.67
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 13.77
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 92.63
9-Day RSI 83.41
14-Day RSI 75.62
6-1 Month Momentum % -18.96
12-1 Month Momentum % 22.09

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.61
Quick Ratio 8.51
Cash Ratio 8.13
Days Inventory 37.75
Days Sales Outstanding 5.96
Days Payable 68.69

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -8.5
Shareholder Yield % -1.31

Financials (Next Earnings Date:2024-03-11)

LEGN's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:LEGN

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Legend Biotech Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 233.312
EPS (TTM) ($) -2.96
Beta -0.2
Volatility % 49.82
14-Day RSI 75.62
14-Day ATR ($) 2.328581
20-Day SMA ($) 59.9105
12-1 Month Momentum % 22.09
52-Week Range ($) 42.905 - 77.32
Shares Outstanding (Mil) 182.29

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Legend Biotech Corp Filings

Filing Date Document Date Form
No Filing Data

Legend Biotech Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Legend Biotech Corp Frequently Asked Questions

What is Legend Biotech Corp(LEGN)'s stock price today?
The current price of LEGN is $67.78. The 52 week high of LEGN is $77.32 and 52 week low is $42.91.
When is next earnings date of Legend Biotech Corp(LEGN)?
The next earnings date of Legend Biotech Corp(LEGN) is 2024-03-11.
Does Legend Biotech Corp(LEGN) pay dividends? If so, how much?
Legend Biotech Corp(LEGN) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1